September 4, 2013
Webinar
IP lawyers need to keep current with the growing body of case law from the Federal Circuit. Those decisions affect a company’s IP portfolio strategy on many levels in significant, and sometimes subtle, ways. Some decisions have particular importance and deserve a closer look.
Please join our panelists as they discuss patentable subject matter involving DNA and computer-related inventions, the decisions and considerations for the future:
Association for Molecular Pathology v. Myriad Genetics (2013)
• In this landmark case involving the so-called breast cancer gene, the Supreme Court drew a line between isolated DNA (not patentable subject matter) and cDNA (patentable subject matter).
• Outlining the Supreme Court’s rationale, we will discuss strategies for moving forward in light of not only the Myriad case, but also the Supreme Court’s decision regarding diagnostic methods in Mayo v. Prometheus.
CLS Bank v. Alice Corp. (Fed. Cir. 2013)(en banc)
• Rather than the clear guidance for patenting computer-related inventions that many had hoped for, this en banc decision resulted in seven different opinions, with only a two-sentence per curium opinion garnering a majority. The decision raised more questions than it answered about the scope of patent protection available to computer-related inventions.
Ultramercial v. Hulu (Fed. Cir. 2013)
• In the wake of CLS Bank, the Federal Circuit held that a series of steps related to displaying ads to customers over the Internet was patent-eligible subject matter under section 101.
Speakers:
J. Michael Jakes
Barbara R. Rudolph, Ph.D.
Date:
Wednesday, September 4, 2013
1:00-2:00 p.m. EDT
June 10-12, 2024
San Francisco
Lecture
Patent Protection for Software-Related Inventions in Europe and the USA Training Course
June 5, 2024
Hybrid
Webinar
Obviousness of Biologics Inventions: Strategies for Biologics Claims in the U.S., Europe, and China
May 28,2024
Webinar
Webinar
Building a Strong ADC Patent Portfolio – From Prosecution and Litigation Perspectives
May 15, 2024
Webinar
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.